Page last updated: 2024-10-30

mimosine and Breast Neoplasms

mimosine has been researched along with Breast Neoplasms in 4 studies

Mimosine: 3-Hydroxy-4-oxo-1(4H)-pyridinealanine. An antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"Mimosine is a toxic nonprotein amino acid that is a major constituent of the tropical legumes Leucaena and Mimosa."5.29Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells. ( Kulp, KS; Vulliet, PR, 1996)
"Mimosine is a toxic nonprotein amino acid that is a major constituent of the tropical legumes Leucaena and Mimosa."1.29Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells. ( Kulp, KS; Vulliet, PR, 1996)
"Mimosine is a potent reversible late G1 phase blocker of the cell cycle."1.29p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine. ( Alpan, RS; Pardee, AB, 1996)
"Treating breast cancer cells with 400 microM mimosine for 24 h inhibited cyclin E- and cyclin A-associated kinase activity by 85% or more, although immunoblots using anti-cyclin A, cyclin E, cdc2, and cdk2 antibodies showed that these key subunits were still present in the cells at pretreatment levels."1.29Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells. ( Green, SL; Kulp, KS; Vulliet, PR, 1996)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iglesias, P1
Penas, C1
Barral-Cagiao, L1
Pazos, E1
Costoya, JA1
Kulp, KS2
Vulliet, PR2
Alpan, RS1
Pardee, AB1
Green, SL1

Other Studies

4 other studies available for mimosine and Breast Neoplasms

ArticleYear
A Bio-inspired Hypoxia Sensor using HIF1a-Oxygen-Dependent Degradation Domain.
    Scientific reports, 2019, 05-08, Volume: 9, Issue:1

    Topics: Animals; Biosensing Techniques; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cobalt; Female; Fl

2019
Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells.
    Toxicology and applied pharmacology, 1996, Volume: 139, Issue:2

    Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cell Survival; Deferoxamine; DNA, Neoplasm; Dose-Respon

1996
p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1996, Volume: 7, Issue:7

    Topics: Breast Neoplasms; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Female; Humans; Mimosi

1996
Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells.
    Experimental cell research, 1996, Nov-25, Volume: 229, Issue:1

    Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cell Line; Cyclin D; Cyclin-Dependent Kinase 4; Cyclin-

1996